Similar medicinal products containing somatropin (Annex to guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues)

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMEA/CHMP/BMWP/94528/2005
Published22/02/2006
Effective from01/06/2006
KeywordsSomatropin, recombinant, similar biological medicinal products, comparability, non-clinical studies, clinical studies, indication, extrapolation
DescriptionThis document is an annex to the guideline on similar biological medicinal products containing monoclonal antibodies: non-clinical and clinical issues. It lays down the non-clinical and clinical requirements for somatropin-containing medicinal products claiming to be similar to another one already marketed.


Related content


How helpful is this page?

Average rating:

 Based on 4 ratings

Add your rating:

See all ratings
1 ratings
0 ratings
0 ratings
0 ratings
3 ratings
    

Tell us more